What People Think
 |
 |
37% For, 63% Against
Take Action
| Vote on this Bill | |
  |
For |
  |
Against |
| Speak Out | |
  |
Comment on this Bill |
  |
Alert Your Friends and Colleagues |
  |
Write Your Representative in Congress |
| Save & Share | |
 |
del.icio.us |
 |
Digg |
 |
|
 |
|
 |
|
 |
Yahoo! |
S. 623, The Access to Life-Saving Medicine Act
You must be logged in to your WashingtonWatch.com account in order to edit this wiki page.
(Learn how to edit the WashingtonWatch.com wiki.)
Don't have an account? Register for your free account now!
Learn More
Trackback URL: http://www.washingtonwatch.com/bills/trackback/110_SN_623.html
RSS Feeds for This Bill
Keep yourself updated on user contributions and debates about this bill! (Learn more about RSS.)
Visitor Comments
trinsic
From a quick read of this bill it looks like it forces the food and drug administration to release drugs too quickly and severely restricts due process when complaints are filed against a drug product, it also has language that is designed to lessen the impact of public comments that favor against any drug product.
Basically it makes it easier to release drugs before they are ready and limits speech against drug products. I doesn't look like it has much to do with the specifics of life saving drugs, more like its another attempt to lessen public outcry and necessary testing for health concerns.
Disease Survivor
I hope this bill passes as written. FDA should be the ones making decisions on what they need to evaluate, how long, etc. Isn't that what they do? If I can get the same drug for less money I need that help! I commend Senator Schumer for introducing this bill and I hope the big drug companies interests in profits doesn't drown out paitents needs.
Beyond the Veil
Those words sound more like they came from a pharmaceutical representative. The legislation actually hinds the FDA in verifying the safety and efficacy of the medications, gives the insurance final product prescription regardless of physician preference, and compromises an innovative company’s ability to recoup investments incurred during research and development. Schumer, Waxman, & Hatch may have sponsored the bill but it is the product of big insurance, big business, and major pharmaceutical companies. Just look for the coalition lobbying in support of the legislation.